Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Billard

Showing results (931-940 of 1,039) with videos related to

Pageof 104
Sort By:
Bioorganic & Medicinal Chemistry Letters|September 30, 2000
Diphenylsulfone muscarinic antagonists: piperidine derivatives with high M2 selectivity and improved potencyW Billard, H Binch, K Bratzler, et al.
International Journal of Cancer|February 11, 2020
Colibactin-positive Escherichia coli induce a procarcinogenic immune environment leading to immunotherapy resistance in colorectal cancerAmélie Lopès, Elisabeth Billard, Al Hassan Casse, et al.
Head & Neck|December 5, 2019
Induction chemotherapy followed by radiotherapy for N3 head and neck squamous cell carcinomaChengrun Du, Pierre Blanchard, Caroline Even, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2000
Diphenyl sulfoxides as selective antagonists of the muscarinic M2 receptorJ A Kozlowski, D B Lowe, H S Guzik, et al.
The Journal of Hospital Infection|April 29, 2008
Field test comparison of two dermal tolerance assessment methods of hand hygiene productsR Girard, E Carré, S Pires-Cronenberger, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 1996
Deficits in memory and hippocampal long-term potentiation in mice with reduced calbindin D28K expressionS Molinari, R Battini, S Ferrari, et al.
Infectious Diseases Now|September 5, 2022
Tuberculosis treatment outcomes among precarious patients in FranceF Méchaï, D Bachelet, L Han, et al.
Cell Death and Differentiation|June 30, 2012
Unveiling an exceptional zymogen: the single-chain form of tPA is a selective activator of NMDA receptor-dependent signaling and neurotoxicityJ Parcq, T Bertrand, A Montagne, et al.
Bioorganic & Medicinal Chemistry Letters|January 2, 2001
Benzylidene ketal derivatives as M2 muscarinic receptor antagonistsC D Boyle, S Chackalamannil, L Y Chen, et al.
Molecular Pharmaceutics|August 14, 2013
Assessing the dual activity of a chalcone-phthalocyanine conjugate: design, synthesis, and antivascular and photodynamic propertiesSinem Tuncel, Aurélien Trivella, Devrim Atilla, et al.
Pageof 104

Showing results (931-940 of 1,039) with videos related to

Sort By:
Pageof 104
Bioorganic & Medicinal Chemistry Letters|September 30, 2000
Diphenylsulfone muscarinic antagonists: piperidine derivatives with high M2 selectivity and improved potencyW Billard, H Binch, K Bratzler, et al.
International Journal of Cancer|February 11, 2020
Colibactin-positive Escherichia coli induce a procarcinogenic immune environment leading to immunotherapy resistance in colorectal cancerAmélie Lopès, Elisabeth Billard, Al Hassan Casse, et al.
Head & Neck|December 5, 2019
Induction chemotherapy followed by radiotherapy for N3 head and neck squamous cell carcinomaChengrun Du, Pierre Blanchard, Caroline Even, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2000
Diphenyl sulfoxides as selective antagonists of the muscarinic M2 receptorJ A Kozlowski, D B Lowe, H S Guzik, et al.
The Journal of Hospital Infection|April 29, 2008
Field test comparison of two dermal tolerance assessment methods of hand hygiene productsR Girard, E Carré, S Pires-Cronenberger, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 1996
Deficits in memory and hippocampal long-term potentiation in mice with reduced calbindin D28K expressionS Molinari, R Battini, S Ferrari, et al.
Infectious Diseases Now|September 5, 2022
Tuberculosis treatment outcomes among precarious patients in FranceF Méchaï, D Bachelet, L Han, et al.
Cell Death and Differentiation|June 30, 2012
Unveiling an exceptional zymogen: the single-chain form of tPA is a selective activator of NMDA receptor-dependent signaling and neurotoxicityJ Parcq, T Bertrand, A Montagne, et al.
Bioorganic & Medicinal Chemistry Letters|January 2, 2001
Benzylidene ketal derivatives as M2 muscarinic receptor antagonistsC D Boyle, S Chackalamannil, L Y Chen, et al.
Molecular Pharmaceutics|August 14, 2013
Assessing the dual activity of a chalcone-phthalocyanine conjugate: design, synthesis, and antivascular and photodynamic propertiesSinem Tuncel, Aurélien Trivella, Devrim Atilla, et al.
Pageof 104